337 related articles for article (PubMed ID: 21254180)
1. Noninvasive assessment of liver fibrosis.
Martínez SM; Crespo G; Navasa M; Forns X
Hepatology; 2011 Jan; 53(1):325-35. PubMed ID: 21254180
[TBL] [Abstract][Full Text] [Related]
2. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive methods to assess liver disease in patients with hepatitis B or C.
Castera L
Gastroenterology; 2012 May; 142(6):1293-1302.e4. PubMed ID: 22537436
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive assessment of fibrosis and steatosis in NASH and ASH.
Angulo P
Gastroenterol Clin Biol; 2009; 33(10-11):940-8. PubMed ID: 19800187
[TBL] [Abstract][Full Text] [Related]
5. Noninvasive monitoring of patients with chronic hepatitis C.
Fontana RJ; Lok AS
Hepatology; 2002 Nov; 36(5 Suppl 1):S57-64. PubMed ID: 12407577
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of various noninvasive serum markers of liver fibrosis in chronic viral liver disease].
Kim SM; Sohn JH; Kim TY; Roh YW; Eun CS; Jeon YC; Han DS; Oh YH
Korean J Hepatol; 2009 Dec; 15(4):454-63. PubMed ID: 20037264
[TBL] [Abstract][Full Text] [Related]
7. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients.
Cho HJ; Seo YS; Lee KG; Hyun JJ; An H; Keum B; Kim JH; Yim HJ; Jeen YT; Lee HS; Chun HJ; Um SH; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2011 Mar; 26(3):492-500. PubMed ID: 21332545
[TBL] [Abstract][Full Text] [Related]
8. Noninvasive markers of fibrosis and inflammation in clinical practice: prospective comparison with liver biopsy.
Anastasiou J; Alisa A; Virtue S; Portmann B; Murray-Lyon I; Williams R
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):474-80. PubMed ID: 19887952
[TBL] [Abstract][Full Text] [Related]
9. Assessing liver fibrosis.
Castera L
Expert Rev Gastroenterol Hepatol; 2008 Aug; 2(4):541-52. PubMed ID: 19072402
[TBL] [Abstract][Full Text] [Related]
10. Application of the HALF index obviates the need for liver biopsy in half of all patients with chronic hepatitis B.
Lee HJ; Seo YS; Kim DJ; Kang HS; An H; Kim JH; Cheong JY; Yim HJ; Yeon JE; Lee HS; Byun KS; Cho SW; Kim DJ; Um SH; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2011 Jun; 26(6):987-95. PubMed ID: 21198828
[TBL] [Abstract][Full Text] [Related]
11. How far is noninvasive assessment of liver fibrosis from replacing liver biopsy in hepatitis C?
Sebastiani G; Alberti A
J Viral Hepat; 2012 Jan; 19 Suppl 1():18-32. PubMed ID: 22233410
[TBL] [Abstract][Full Text] [Related]
12. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
[TBL] [Abstract][Full Text] [Related]
14. Noninvasive diagnosis of liver fibrosis in patients with HIV infection and HCV/HBV co-infection.
Moreno S; García-Samaniego J; Moreno A; Ortega E; Pineda JA; del Romero J; Tural C; von Wichmann MA; Berenguer J; Castro A; Espacio R
J Viral Hepat; 2009 Apr; 16(4):249-58. PubMed ID: 19215579
[TBL] [Abstract][Full Text] [Related]
15. Comparison of transient elastography and liver biopsy for the assessment of liver fibrosis in HIV/hepatitis C virus-coinfected patients and correlation with noninvasive serum markers.
Sánchez-Conde M; Montes-Ramírez ML; Miralles P; Alvarez JM; Bellón JM; Ramírez M; Arribas JR; Gutiérrez I; López JC; Cosín J; Alvarez E; González J; Berenguer J
J Viral Hepat; 2010 Apr; 17(4):280-6. PubMed ID: 19732322
[TBL] [Abstract][Full Text] [Related]
16. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
[TBL] [Abstract][Full Text] [Related]
17. Staging of liver disease: which option is right for my patient?
Bhogal H; Sterling RK
Infect Dis Clin North Am; 2012 Dec; 26(4):849-61. PubMed ID: 23083819
[TBL] [Abstract][Full Text] [Related]
18. Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with nonalcoholic fatty liver disease (NAFLD).
Yoneda M; Yoneda M; Mawatari H; Fujita K; Endo H; Iida H; Nozaki Y; Yonemitsu K; Higurashi T; Takahashi H; Kobayashi N; Kirikoshi H; Abe Y; Inamori M; Kubota K; Saito S; Tamano M; Hiraishi H; Maeyama S; Yamaguchi N; Togo S; Nakajima A
Dig Liver Dis; 2008 May; 40(5):371-8. PubMed ID: 18083083
[TBL] [Abstract][Full Text] [Related]
19. Performance of noninvasive markers for liver fibrosis is reduced in chronic hepatitis C with normal transaminases.
Sebastiani G; Vario A; Guido M; Alberti A
J Viral Hepat; 2008 Mar; 15(3):212-8. PubMed ID: 18179453
[TBL] [Abstract][Full Text] [Related]
20. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
